{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "Pharmacologic Substance[C1909]|Biological Agent[C307]|Antigen[C268]" in comments (approximate match)
Status:
US Approved Rx
(1977)
First approved in 1977
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
Canada:MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
Canada:MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
Canada:MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
Canada:MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y
Source URL:
Class:
POLYMER
Status:
US Approved Rx
(2010)
First approved in 2010
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2010)
First approved in 2010
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2010)
First approved in 2010
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2010)
First approved in 2010
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2010)
First approved in 2010
Class:
STRUCTURALLY DIVERSE